Most peptide vendors talk about purity. Peptidology’s edge is that it documents more than purity.
Each lot is released through a structured analytical verification process designed to give researchers a deeper picture of what they are buying. This includes not only identity and purity testing, but also additional screening that can matter in more sensitive research settings.
Peptidology reports:
- Purity of 99% or greater per lot
- Bacterial endotoxin testing per lot
- Elemental impurity screening for heavy metals per lot
- Microbial contamination testing by two independent laboratories
- Lot-specific Certificates of Analysis tied to the specific batch
- A structured 7-point analytical verification program
That matters because purity alone does not tell the full story. In research workflows, especially cell-based assays and other sensitive environments, endotoxins, trace contaminants, and microbial issues can affect outcomes in ways a simple purity result will not reveal.
Third-Party Verification and Documentation
Peptidology’s third-party testing is conducted by Vanguard Laboratories, a United States-based analytical laboratory accredited to ISO/IEC 17025:2017 standards.
That accreditation matters because it means the lab’s testing systems and measurement processes have been independently validated. This is a different standard than simply claiming third-party testing without meaningful laboratory credentials.
Peptidology also states that its raw peptide ingredients come from an FDA-registered and audited manufacturer, and that final production is handled in a GMP-certified or GMP-compliant contract manufacturing facility.
The result is a vendor profile built around documentation, traceability, and contaminant awareness rather than marketing language alone.